ADENOSQUAMOUS CARCINOMA OF THE PANCREAS
Clinical trials for ADENOSQUAMOUS CARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new ADENOSQUAMOUS CARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for ADENOSQUAMOUS CARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo strategy aims to outsmart pancreatic cancer
Disease control Recruiting nowThis phase 2 trial tests a new approach for people with metastatic pancreatic cancer: alternating two standard chemotherapy regimens every month instead of using just one. The goal is to see if this switching strategy can keep the cancer from growing for at least 6 months. About …
Matched conditions: ADENOSQUAMOUS CARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Blood test may speed up chemo decisions for deadly pancreatic cancer
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for tumor DNA (ctDNA) can tell doctors within weeks if chemotherapy is shrinking a patient's pancreatic cancer. Currently, doctors wait about 8 weeks for a scan to see if treatment is working. The trial will enroll 50 people w…
Matched conditions: ADENOSQUAMOUS CARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC